Vincerx Pharma, Inc.

VINCW | NASDAQ | 0 Sledující

$1.61

-20.69%

-$0.42

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	0 -100.00%	915 -2.56%	939 +176.18%	340 -
Gross profit	0 +100.00%	-915 +2.56%	-939 -176.18%	-340 -
Operating expense	31,463 -26.16%	42,609 -40.08%	71,105 +13.48%	62,656 -
Operating income	-31,463 +26.16%	-42,609 +42.09%	-73,574 -17.43%	-62,656 -
Pretax Income	-30,074 +25.11%	-40,157 +38.57%	-65,367 -66.30%	-39,306 -
Tax Provision	0 -	0 +100.00%	-8,207 +65.37%	-23,698 -
Net income	-30,074 +25.11%	-40,157 +29.75%	-57,160 -266.22%	-15,608 -
EPS	-15.85 -738.62%	-1.89 +30.51%	-2.72 -198.90%	-0.91 -
Diluted EPS	-15.85 -738.62%	-1.89 +30.51%	-2.72 -198.90%	-0.91 -
Average Shares	1,898 -91.09%	21,295 +1.26%	21,029 +22.43%	17,176 -
Diluted Average Shares	1,898 -91.09%	21,295 +1.26%	21,029 +22.43%	17,176 -
EBIT	0 +100.00%	-42,609 +38.00%	-68,722 -9.68%	-62,656 -
EBITDA	-31,463 +26.16%	-42,609 +37.95%	-68,668 -9.60%	-62,656 -

Soubory cookie používáme ke zlepšení prohlížení na webu.